New injection option for CIDP patients currently on IVIg?

NCT ID NCT06637072

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times

Summary

This study looked at whether adults with CIDP, a nerve disorder, could switch from their regular IVIg infusions to a new injected medicine called efgartigimod PH20 SC. 23 participants stopped IVIg and started the new treatment, staying on it for 12 weeks. The main goal was to see how many could successfully make the switch and continue the new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cedar Health Research - Dallas

    Dallas, Texas, 75251, United States

  • Erlanger Neuroscience Institute

    Chattanooga, Tennessee, 37403, United States

  • Horizon Clinical Research: Gill Neuroscience

    Cypress, Texas, 21216, United States

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia, 20010, United States

  • National Neuromuscular Research Institute

    Austin, Texas, 78759, United States

  • Neurology Associates PA

    Maitland, Florida, 32751, United States

  • Northwest Houston Neurology - Cypress

    Cypress, Texas, 77429, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, 60611, United States

  • SRI International - ClinEdge

    Plymouth, Michigan, 48170, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Velocity Clinical Research

    Lafayette, Louisiana, 70508, United States

  • Velocity Clinical Research

    Raleigh, North Carolina, 27607, United States

  • Visionary Investigators Network

    Miami, Florida, 33180, United States

Conditions

Explore the condition pages connected to this study.